Sarepta therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4)

Cambridge, mass.--(business wire)--sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, granted equity awards on september 30, 2024 (the “grant date”) that were previously approved by the compensation committee of its board of directors under sarepta's 2024 employment commencement incentive plan, as a material inducement to employment to 28 individuals hired by sarepta in september 2024. the equity awards were approved in accordance with nasdaq l.
NDAQ Ratings Summary
NDAQ Quant Ranking